Difficulty: Medium
Average Score: 92%
Practice
A 66-year-old woman who has smoked two packs of cigarettes per day for 50 years has chronic bronchitis. She has tried to quit five times in the past but felt she could not go long without a cigarette. The nicotine in her cigarettes stimulates many cells in her body by binding certain receptors. Which of the following drugs blocks nicotinic receptors?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Hexamethonium, a ganglionic blocking agent that acts by blocking nicotinic receptors. In the context of a chronic smoker with bronchitis, blocking nicotinic receptors can help reduce the addictive effects of nicotine and potentially aid in smoking cessation.
Atropine (A) is a muscarinic antagonist and would not block nicotinic receptors. Bethanechol (B) is a cholinergic agonist used to stimulate bladder contractions and would not block nicotinic receptors. Metoprolol (D) is a beta-blocker and would not act on nicotinic receptors.
Educationally, understanding the specific mechanisms of action of drugs is crucial in pharmacology to ensure appropriate drug selection for different conditions. In this case, knowing that Hexamethonium blocks nicotinic receptors can help in managing nicotine addiction and its effects on the body. This knowledge is essential for healthcare professionals in making informed decisions regarding drug therapy for patients.
Atropine (A) is a muscarinic antagonist and would not block nicotinic receptors. Bethanechol (B) is a cholinergic agonist used to stimulate bladder contractions and would not block nicotinic receptors. Metoprolol (D) is a beta-blocker and would not act on nicotinic receptors.
Educationally, understanding the specific mechanisms of action of drugs is crucial in pharmacology to ensure appropriate drug selection for different conditions. In this case, knowing that Hexamethonium blocks nicotinic receptors can help in managing nicotine addiction and its effects on the body. This knowledge is essential for healthcare professionals in making informed decisions regarding drug therapy for patients.